Similar Items: Shifting a paradigm: highlights of model informed drug development in dosage selection and optimization for oncology products
- Optimal management of venous thromboembolism in adolescent and young adult oncology patients
- Implementing UK Oncology Nursing Society–Informed Digital Symptom Triage With Episode-Based Review in Routine NHS Acute Oncology: Service Evaluation
- Mitotane dosage, plasma levels, and anthropometric measurements in pediatric adrenocortical carcinoma
- Still human: Presence, oncology, and artificial intelligence
- Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic Experts
- Withstanding the test of time for patients in oncology clinical trials